Fourteen patients witii vascular disease were studied to evaluate the efficacy of niordipine hydrochloride u a hypotensive agent in the treatment of acute hypertension occurring during anaesthesia. Five patients received a bolus injection of nicardipine hydrochloride 0.5 ing. Another ninr patients received bolus injections of nicardipine 1 and 2 mg. NJcardipine 0.5 mg significantly decreased systemic arterial pressure (by about 24%), systemic vascular resistance (SVR), left ventricular stroke work index (LVSWI) and rate-pressure product (RPP). Nicardipine 1 or 2 mg had twice the effect in decreasing arterial pressure as did 0.5 mg, without significant change in heart rate or right and left ventricular filling pressures. Cardiac index and stroke volume index increased and SVR, pulmonary vascular resistance, LVSWI and RPP decreased significantly. 
Nicardipine hydrochloride (2,6-dimethyl-4(3-nitrophenyl)-l, 4-dihydropyridine-3, 5-dicarboxylic acid 3-(2-(N-benzyl-N-methylamino))-ethyl ester 5-methyl ester hydrochloride) is a new calcium entry blocker with potent vasodilatory and hypotensive properties. Nicardipine is about 100 times more potent than papaverine in causing cerebral and coronary vasodilatation and appears to act directly on vascular smooth muscle cells without involving specific receptors such as alpha-or beta-adrenergic, cholinergic, and adenosine receptors (Takenaka et al., 1976) . The mechanism of the vasodilator action of nicardipine is thought to be by means of interference with Ca 2+ influx (Endoh, Yanagisawa and Taira, 1980; Tend, Takenaka and Maeno, 1981) .
Nicardipine is a water soluble and light insensitive dihydropyridine derivative (Iwanami et al., 1979) 
PATIENTS AND METHODS
Fourteen patients (13 male) with vascular disease were studied during vascular surgery. Their ages ranged from 13 to 74 yr. Eight patients had a history of hypertension and were receiving antihypertensive medication: trichlormethiazide, nifedipine and methyldopa. These were discontinued 24 h before surgery to avoid any interaction between these drugs and nicardipine. ECG studies confirmed the absence of myocardial infarction in all patients. No patient had congestive heart failure. Informed consent was obtained from each patient before surgery.
All patients were premedicated with atropine 0.5 mg and pethidine 50 mg i.m. 45 min before arrival in the operation theatre. Anaesthesia was induced with thiamylal, and pancuronium was given to facilitate trachea] intubation. Ventilation was controlled to maintain Pao^ above 13.3 kPa and •Pacxh at approximately 5.3 kPa. Anaesthesia was maintained with 60% nitrous oxide and increments of fentanyl and diazepam.
When the systolic arterial pressure (SAP) increased by 50% more than its preoperative value, or was more than 180mmHg despite the administration of fentanyl 20figkg -1 and diazepam 20 mg, haemodynamic measurements were performed (control).
In the initial study, nicardipine 0.5 mg was administered to five anaesthetized patients and the general haemodynamic effects noted. Following the control measurements, a bolus of 0.5 mg was administered and a second series of measurements obtained once SAP had attained its lowest value.
In the subsequent study, nicardipine 1 and 2 mg was administered to nine patients during anaesthesia to determine the dose which would decrease systemic arterial pressure to its preoperative value. Nicardipine 1 mg (bolus) was administered following the control measurements. The second series of measurements was obtained as described for nicardipine 0.5 mg. The third series of measurements was obtained once SAP had returned to control. Nicardipine 2 mg (bolus) was then administered to seven of the nine patients; because of massive bleeding the study was discontinued in two patients. Haemodynamic measurements were obtained once SAP had reached its lowest value.
A 20-gauge cannula was inserted to a radial artery for measurement of the systemic arterial pressure and a triple-lumen thermodilution pulmonary artery catheter (Edwards) placed in a pulmonary artery via the right internal jugular vein. Pressure was measured with calibrated pressure transducers (Hewlett-Packard 1280C) and an eight-channel amplifying system (Hewlett-Packard). Cardiac output was determined in duplicate by thermodilution (Hewlett-Packard 78231C).
Measurements included heart rate (HR), SAP, mean arterial pressure (MAP), diastolic arterial pressure (DAP), mean pulmonary arterial pressure (MPAP), mean pulmonary capillary wedge pressure (PCWP), right atrial pressure (RAP) and cardiac output (CO). Systemic vascular resistance (SVR), pulmonary vascular resistance (PVR.), cardiac index (CI), stroke volume index (SVI), left ventricular stroke work index (LVSWI), right ventricular stroke work index (RVSWI) and rate-pressure product (RPP) were derived using standard formulae. This study was not conducted within 1 h of the commencement of surgery, nor during the period of aortic cross-clamping.
Statistical analysis was performed to compare the results with the control, using the paired Student's t test.
TABLE I. Summary of haemodynamic findings (mean ± SD). Abbreviations: HR" heart rate; SAP'=systolic arterial prtssurt; MAP" mean arterial pressure; DAP = diastolic arterial pressurt; PCWP=mean pulmonary arterial wedge pressure; MPAP •= mean pulmonary arterial pressure; RAP=-right atrial prtssurt; CI=* cardiac index; SVR-systemic vascular resistance; PVR -pulmonary vascular resistance; LVSWI=-left ventricular stroke work index; RVSWI-right ventricular stroke work index; RPP = rate-prtssurt product. *P <0.05; **P <0.01; ***P <0.001 compared with control 
RESULTS
Haemodynamic results are summarized in table I. Nicardipine 0.5 ing decreased SAP by about 17%, and nicardipine 1 and 2 mg decreased SAP and DAP by about 35%: the maximum effects being evident about 2.5 min after administration. The period required for SAP to return to its control value was 7 min following nicardipine 0.5 mg, and 23 min and 19 min for nicardipine 1 and 2 mg, respectively ( fig.  1 ). Severe hypotension was not observed. Nicardipine 1 and 2mg significantly decreased SVR, PVR, LVSWI and RPP. CI was increased as a result of a significant increase in SVI ( fig. 2) . Nicardipine 1 and 2 mg did not affect HR, PCWP, MPAP or RAP ( fig. 2) . Although SAP returned to the control value after nicardipine 1 mg, MAP, DAP, SVR and PVR were significantly less than the control. There were no significant differences between the effects produced by nicardipine 1 or 2 mg. Nicardipine 0.5 mg significantly decreased SVR, LVSWI and RPP. However, these changes were less marked than those obtained following nicardipine 1 or 2 mg.
DISCUSSION
Nicardipine acts on the cardiovascular system by inhibiting the influx of Ca 2+ (Endoh, Yanagisawa and Taira, 1980; Terai, Takenaka and Maeda, 1981) . Other investigators have showed that nicardipine has more effect on the peripheral vessels than on the heart (Seki and Takenaka, 1977) . Acute hypertension may increase the risk of acute left heart failure and cerebral accident, and the amount of bleeding from suture lines (Estafanous and Tarazi, 1980) . Thus, it is necessary to control the systemic arterial pressure promptly and effectively. When used for this purpose, nicardipine decreased SAP and SVR with little influence on left or right ventricular filling pressures, indicating that nicardipine causes dilatation of arterioles with minimal effect on the venules. The onset of its action is rapid and its duration of action fairly short.
It could be expected that the decrease in SAP would induce a reflex increase in heart rate which could be detrimental to patients with coronary artery disease because of the increase in myocardial oxygen consumption. However, heart rate did not increase in this study. Previously, Satoh, Yanagisawa and Taira (1980) demonstrated that nicardipine decreased sinus rate and increased atrio-ventricular conduction time. The present study might also show a negative chronotropic effect of nicardipine.
A decrease in afterload contributed greatly to the increase in cardiac output and stroke volume. Therefore, the inotropic effect of nicardipine hydrochloride could not be evaluated.
Calcium entry blockers decrease increased pulmonary arterial pressures, but not normal pressure (Reves et al., 1982) . In this study, nicardipine did not alter pulmonary arterial pressure. However, calculated pulmonary vascular resistance was decreased significantly. Further investigations are necessary to determine whether nicardipine specifically decreases pulmonary vascular resistance in normal lung.
An interaction between nicardipine and other drugs used for anaesthetic management should be considered, since general anaesthetics are usually cardiodepressants and vasodilators. These effects are at least in part related to interference with transmembrane and intracellular movement or translocation of Ca Nicardipine 10 and 20jzgkg~' administered i.v. produced a dose-dependent decrease in arterial pressure without depressing cardiac function in healthy awake volunteers (Seki and Takenaka, 1977) . Therefore, we used 0.5 mg to examine the haemodynamic effects in anaesthetized patients. Nicardipine 1 mg decreased arterial pressure by 34%, which was sufficient to return arterial pressure to the preoperative value. Haemodynamic effects of 1 and 2 mg were almost identical. This suggests that there might be an element of tachyphylaxis.
